Maternal cardiomyopathy increases the risk of perinatal adverse outcomes: a response

Affiliations

¹ The Medical School, Newcastle University, Newcastle upon Tyne, United Kingdom.
² East Surrey Hospital, Surrey and Sussex Healthcare NHS Trust, Surrey, United Kingdom.
³ Department of Obstetrics and Gynaecology, Rosie Hospital and National Institute for Health and Care Research Cambridge Biomedical Research Centre, University of Cambridge, Box 223, Cambridge, CB2 0SW, United Kingdom. Electronic address: cema2@cam.ac.uk.

Comment

Elizabeth J Eggleton et al. Am J Obstet Gynecol. 2023 Apr.

. 2023 Apr;228(4):486-487.

doi: 10.1016/j.ajog.2022.11.1311. Epub 2022 Dec 5.

¹ The Medical School, Newcastle University, Newcastle upon Tyne, United Kingdom.
² East Surrey Hospital, Surrey and Sussex Healthcare NHS Trust, Surrey, United Kingdom.
³ Department of Obstetrics and Gynaecology, Rosie Hospital and National Institute for Health and Care Research Cambridge Biomedical Research Centre, University of Cambridge, Box 223, Cambridge, CB2 0SW, United Kingdom. Electronic address: cema2@cam.ac.uk.

No abstract available

Comment on

Perinatal outcomes in pregnancies complicated by maternal cardiomyopathy: a systematic review and meta-analysis.
Eggleton EJ, McMurrugh KJ, Aiken CE. Eggleton EJ, et al. Am J Obstet Gynecol. 2023 Mar;228(3):283-291. doi: 10.1016/j.ajog.2022.09.025. Epub 2022 Sep 20. Am J Obstet Gynecol. 2023. PMID: 36150520
Perinatal outcomes in pregnancies complicated by maternal cardiomyopathy: a letter.
Sarkar A, Gupta M, Jesingh B, Chandra R. Sarkar A, et al. Am J Obstet Gynecol. 2023 Apr;228(4):486. doi: 10.1016/j.ajog.2022.12.003. Epub 2022 Dec 5. Am J Obstet Gynecol. 2023. PMID: 36470317 No abstract available.